The COVID-19 pandemic struck an unprepared globe, demonstrating a clear lack of infrastructure and response capabilities despite robust intergovernmental discussions on pandemic preparedness. Even as we endeavour to move beyond this crisis, it is disconcerting to note that vital lessons appear to be slipping into oblivion. Three years hence, numerous articles and debates emphasize the importance of heeding the lessons of COVID-19 to better navigate future healthcare threats, but evidence suggests a disturbing amnesia about some basic understandings.
Despite irrefutable evidence of the efficacy of masks in curtailing the spread of respiratory pathogens, including SARS-CoV-2, mask mandates have been largely discontinued globally. This holds true even in healthcare settings where the possibility of encountering contagious individuals or those with compromised immune systems is high. In such environments, masks act as crucial physical barriers, inhibiting transmission from carriers and preventing non-carriers from inhaling pathogen-laden respiratory droplets.
While vaccines have undisputedly been successful in reigning in COVID-19, breakthrough infections have occurred. The protective shield provided by vaccines also tends to weaken over time, highlighting the need for obtaining COVID-19 booster shots.
The draft guidance by the U.S. CDC committee on infection control in hospitals implied equivalence between N95 face masks and looser surgical face masks, under specific circumstances. The advice seemed to condone the use of surgical masks alone while caring for patients infected with routine, endemic viruses. The suggested guideline remains in draft stages, with a committee vote slated for late November.
Surveillance and sequencing of infections are vital for tracking the trajectory and evolution of mutating variants, like the heavily mutated Pirola variant of SARS-CoV-2- deemed potentially less recognizable to our immune systems. However, many countries have either ceased or drastically reduced their surveillance efforts, diminishing data accessibility and hampering effective containment strategies.
The pandemic uncannily spotlighted global discrepancies in medical interventions access, not just restricted to COVID-related treatment. Supply chain disruptions aggravated these disparities, particularly for chronic diseases like diabetes and cancer. Ensuring fair access to chronic disease treatments is as important as bracing ourselves for potential infectious pandemic risks.
Source: https://www.gavi.org/vaccineswork/masks-testing-three-key-lessons-weve-already-forgotten-pandemic